|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 169 of 222 found articles
| Title: |
Survie conditionnelle et suivi à 5 ans dans l’étude checkmate 214 : Nivolumab+Ipilimumab (N+I) versus Sunitinib (S) dans le traitement de première ligne du carcinome rénal avancé (ACCR) |
| Author: |
Escudier, B. Tannir, N. Mcdermott, D. Burotto, M. Choueiri, T. Hammers, H. Plimack, E. Porta, C. George, S. Powles, T. Donskov, F. Gurney, H. Kollmannsberger, C. Grimm, M. Tomita, Y. Rini, B. Mchenry, M. Lee, C. Motzer, R. |
| Appeared in: |
Progrès en urologie. FMC |
| Paging: | Volume 31 () nr. 13 pages 837 |
| Year: |
2021 |
| Contents: | |
| Publisher: |
Published by Elsevier B.V. |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 169 of 222 found articles
| << previous | next >> |